000			01671 a2200529 4500
005			20250516053954.0
264		0	_c20120229
008			201202s 0 0 eng d
022			_a2567-689X
024	7		_a10.1160/TH11-05-0353 _2doi
040			_aNLM _beng _cNLM
100	1		_aGallagher, A M
245	0	0	_aRisks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. _h[electronic resource]
260			_bThrombosis and haemostasis _cNov 2011
300			_a968-77 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aAtrial Fibrillation _xblood
650	0	4	_aBlood Coagulation _xdrug effects
650	0	4	_aDatabases as Topic
650	0	4	_aDrug Monitoring _xmethods
650	0	4	_aFemale
650	0	4	_aGeneral Practice
650	0	4	_aHumans
650	0	4	_aInternational Normalized Ratio
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOdds Ratio
650	0	4	_aProportional Hazards Models
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aStroke _xblood
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aUnited Kingdom
650	0	4	_aWarfarin
700	1		_aSetakis, E
700	1		_aPlumb, J M
700	1		_aClemens, A
700	1		_avan Staa, T-P
773	0		_tThrombosis and haemostasis _gvol. 106 _gno. 5 _gp. 968-77
856	4	0	_uhttps://doi.org/10.1160/TH11-05-0353 _zAvailable from publisher's website
999			_c21141523 _d21141523